Skip to content

Medical toxicology and adverse drug experience

ISSN 0113-5244

2 papers in the library · publishing 1988-1989

Papers

Sort Most recent Most cited

Clinical features and management of intoxication due to hallucinogenic drugs.

Medical toxicology and adverse drug experience 1989 J B Leikin, A J Krantz, M Zell-Kanter et al.

Hallucinogenic drugs are unique in that they produce the desired hallucinogenic effects at what are considered non-toxic doses. The hallucinogenic drugs can be categorised into 4 basic groups: indole alkaloid derivatives, piperidine derivatives, phenylethylamines and the cannabinols. The drugs reviewed include lysergic acid diethylamide (LSD), phencyclidine (PCP), cocaine, amphetamines,...

'Designer drugs'. A problem in clinical toxicology.

Medical toxicology and adverse drug experience 1988 J F Buchanan, C R Brown

'Designer drugs' are substances intended for recreational use which are derivatives of approved drugs so as to circumvent existing legal restrictions. The term as popularised by the lay press lacks precision. Contrary to the popular belief that 'designer drugs' are original creations, the majority of these agents are 'borrowed' from legitimate pharmaceutical research. They merely represent the...